Fabrazyme Alternatives Compared
Fabrazyme (agalsidase beta) | Galafold (migalastat) | Agalsidase beta |
|
---|
Fabrazyme (agalsidase beta) | Galafold (migalastat) | Agalsidase beta |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Fabry Disease. Fabrazyme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Fabry Disease. Galafold may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Fabry Disease. Agalsidase beta may also be used for purposes not listed in this medication guide. |
Related suggestions Fabry Disease
|
|||||||
More about Fabrazyme (agalsidase beta) | More about Galafold (migalastat) | More about Agalsidase beta | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Fabrazyme side effects |
View all Galafold side effects |
View all Agalsidase beta side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Galafold prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
|
|
N/A |
||||||||
Brand Names | ||||||||||
N/A |
N/A |
Fabrazyme | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
1.7 hours |
5 hours |
1.7 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 5 drugs are known to interact with Fabrazyme:
|
A total of 1 drugs are known to interact with Galafold:
|
A total of 5 drugs are known to interact with Agalsidase beta:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
April 24, 2003 |
August 10, 2018 |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.